| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 08/31/2000 | WO2000018910A9 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 08/31/2000 | WO2000018906A9 Shuffling of codon altered genes |
| 08/31/2000 | WO2000018882A9 Methods and apparatus for lipid membrane disruption |
| 08/31/2000 | DE19963410A1 New symbiotic microbial association of manganese-oxidizing bacteria and algae useful for recovery of manganese from manganese-containing waters |
| 08/31/2000 | CA2710788A1 Method for the purification, recovery, and sporulation of cysts and oocysts |
| 08/31/2000 | CA2371928A1 Neisserial vaccine compositions and methods |
| 08/31/2000 | CA2365019A1 Novel polypeptide |
| 08/31/2000 | CA2364966A1 Genes encoding insect odorant receptors and uses thereof |
| 08/31/2000 | CA2363794A1 14273 receptor, a novel g-protein coupled receptor |
| 08/31/2000 | CA2363714A1 Avermectin aglycon synthase genes |
| 08/31/2000 | CA2363621A1 A novel inhibitor of programmed cell death |
| 08/31/2000 | CA2363112A1 Neutrokine-alpha and neutrokine-alpha splice variant |
| 08/31/2000 | CA2363106A1 Mdm interacting protein and methods of use thereof |
| 08/31/2000 | CA2362520A1 Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase |
| 08/30/2000 | EP1031628A1 Process for the production of protease inhibitors |
| 08/30/2000 | EP1031627A1 Beta-carotene 15,15'-dioxygenase |
| 08/30/2000 | EP1031578A2 High purity albumin production by a multistep process |
| 08/30/2000 | EP1030930A1 Efficient construction of vectors for gene targeting using phage-plasmid recombination |
| 08/30/2000 | EP1030926A2 Transgenic models of inflammatory disease |
| 08/30/2000 | EP1030925A1 The translation enhancer element of the human amyloid precursor protein gene |
| 08/30/2000 | EP1030924A1 Polypeptides having uroporphyrinogen decarboxylase activity and nucleic acids encoding same |
| 08/30/2000 | EP1030919A2 Cdk2 protein and cdk2 protein complexes |
| 08/30/2000 | EP1030916A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis |
| 08/30/2000 | EP1030912A1 Cell lysis device |
| 08/30/2000 | EP1030911A1 Human aspartic proteases |
| 08/30/2000 | EP1030859A1 Ras-binding protein (pre1) |
| 08/30/2000 | EP1030858A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport |
| 08/30/2000 | EP1030690A1 Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype |
| 08/30/2000 | EP1030685A2 Essential bacterial genes and their use |
| 08/30/2000 | EP1030683A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 08/30/2000 | EP1030566A1 Use of liquid carbohydrate fermentation product in foods |
| 08/30/2000 | EP1030554A1 Method and apparatus for cytoplasmic loading using an impact-mediated procedure |
| 08/30/2000 | EP0248819B2 Recombinant fibroblast growth factors |
| 08/30/2000 | CN1265154A Process for preparing amides |
| 08/30/2000 | CN1265148A Anticoagulant fusion protein anchored to cell membrane |
| 08/30/2000 | CN1265147A Method for producing biotin |
| 08/30/2000 | CN1265146A 细胞分裂素氧化酶 Cytokinin oxidase |
| 08/30/2000 | CN1265145A Hypersensitive response elicitor fragments and uses thereof |
| 08/30/2000 | CN1265141A Use of lactobacillus for reduction of fibrinogen level in blood |
| 08/30/2000 | CN1264734A Cultivating equipment, cultivating method and application of cordy ceps |
| 08/30/2000 | CN1055970C Plasmid derived from lactobacillus delbrueckii SP. |
| 08/30/2000 | CN1055967C Cordyceps sinensis health nutrient liquor produced by deep fermentation method |
| 08/30/2000 | CN1055966C Prodn. of glossy ganoderma health drink by deep fermentation method |
| 08/29/2000 | US6111096 Device for insertion into pressure-modulation apparatus; includes electrode array system, tubes interconnecting the electrodes, and electrical terminals; for highly selective, efficient, low salt process |
| 08/29/2000 | US6111076 Human G-protein coupled receptor (HIBCD07) |
| 08/29/2000 | US6111074 Amino acid sequence of polypeptide from the uridine monophosphate kinase family; for screening bactericides and bacteriostats; for diagnosis and prophylaxis of infections |
| 08/29/2000 | US6111070 Polypeptides encoded by octopine T-DNA open reading frames |
| 08/29/2000 | US6111066 Peptidic molecules which have been isotopically substituted with 13 C, 15 N and 2 H in the backbone but not in the sidechains |
| 08/29/2000 | US6110899 LICC of Streptococcus pneumoniae |
| 08/29/2000 | US6110740 Human vault RNA |
| 08/29/2000 | US6110737 Nucleotide sequence; enhancing response of cells; determining regions involved in signal transduction; drug screening; for mutants; anticarcinogenic agents; wound healing agents; antiproliferative agents; prevention of atherosclerosis |
| 08/29/2000 | US6110735 Method for the preparation of a viral vector by intermolecular homologous recombination |
| 08/29/2000 | US6110725 Lactobacillus strains which survive in the intestine, adhere to human intestinal cells, and increase phagocytosis of macrophages; for preparation of food products |
| 08/29/2000 | US6110719 Phytase |
| 08/29/2000 | US6110715 Cultivating a strain of trichosporonoides megachiliensis in a culture medium at a high saccharide concentration of 20 to 50 w/v% then recovering accumulated product |
| 08/29/2000 | US6110714 Isolated mutant escherichia species which has valine sensitivity, amplified citrate synthase activity and phosphoenolpyruvate carboxylase activity; for efficient biosynthesis |
| 08/29/2000 | US6110706 Amino acid sequences; for increased immunogenicity |
| 08/29/2000 | US6110704 3-ketoacyl-ACP-reductase (FabG) of Staphylococcus aureus |
| 08/29/2000 | US6110702 Nucleotide sequences of which regulate prostate specific antigen; gene therapy; anticarcinogenic agents; recombinant production of proteins |
| 08/29/2000 | US6110701 DNA encoding precursor of interleukin-1β converting enzyme--related cysteine proteinase II (ICErel -II) |
| 08/29/2000 | US6110694 Methods for determining complexes of tumor rejection antigens and HLA-Cw*160/molecules |
| 08/29/2000 | US6110686 DNA hybridizing to a human cystatin-like protein (CSTIN) |
| 08/29/2000 | US6110675 Reagents and methods useful for detecting diseases of the prostate |
| 08/29/2000 | US6110672 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/29/2000 | US6110668 Gene synthesis method |
| 08/29/2000 | US6110661 Bioluminescent reporter bacterium |
| 08/29/2000 | US6110469 Hybrid plasmid for 38 kDa antigen of M. tuberculosis |
| 08/29/2000 | US6110464 Polypeptides with amino acid sequences |
| 08/29/2000 | US6110459 Grafting of myocardium tissues |
| 08/29/2000 | US6110372 Degrading petroleum pollutant comprising compound contained in crude or refined petroleum by treating petroleum pollutant with butane-utilizing bacteria in presence of butane substrate and oxygen |
| 08/29/2000 | US6110271 Methods for improved rheological control in cementitious systems |
| 08/29/2000 | CA2189031C Microbiological medium |
| 08/29/2000 | CA2034487C Dna sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi |
| 08/29/2000 | CA2015687C Human serum albomin fusion polypeptide |
| 08/29/2000 | CA2010275C Pancreatic islet cell antigens obtained by molecular cloning |
| 08/29/2000 | CA1341090C Vampire bat plasminogen activators |
| 08/26/2000 | CA2296792A1 Expressed sequence tags and encoded human proteins |
| 08/24/2000 | WO2000049177A2 HIGH DENSITY SAMPLING OF DIFFERENTIALLY EXPRESSED PROKARYOTIC mRNA |
| 08/24/2000 | WO2000049168A2 Helper adenovirus / helper-dependent adenovirus vector system based on site-specific recombinase activity |
| 08/24/2000 | WO2000049166A2 Production of helper dependent adenovirus vectors based on use of endonucleases |
| 08/24/2000 | WO2000049164A1 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants |
| 08/24/2000 | WO2000049163A1 Production of heterologous polypeptides from freshwater caulobacter |
| 08/24/2000 | WO2000049162A2 Compositions and methods for non-targeted activation of endogenous genes |
| 08/24/2000 | WO2000049155A1 Genes encoding proteins having activity of transferring sugar onto aurone |
| 08/24/2000 | WO2000049152A1 Nucleic acids that code for a nucleobase transporter |
| 08/24/2000 | WO2000049148A1 Novel cytokine recfptor-like protein |
| 08/24/2000 | WO2000049147A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
| 08/24/2000 | WO2000049144A2 Pyk2 binding proteins |
| 08/24/2000 | WO2000049134A1 Secreted proteins and polynucleotides encoding them |
| 08/24/2000 | WO2000049133A1 Method for producing l-sorbose |
| 08/24/2000 | WO2000049043A2 Human lipid-associated proteins |
| 08/24/2000 | WO2000049041A1 Protein preparations |
| 08/24/2000 | WO2000049039A2 Glucose dehydrogenase fusion proteins and their utilization in expression systems |
| 08/24/2000 | WO2000048638A2 Multi-mutant diphtheria toxin vaccines |
| 08/24/2000 | WO2000048629A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
| 08/24/2000 | WO2000048628A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
| 08/24/2000 | WO2000022167A9 Method for determining transcription factor activity and its technical uses |
| 08/24/2000 | WO2000022113A9 ENZYMATIC SYNTHESIS OF ssDNA |
| 08/24/2000 | WO2000022112A9 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 08/24/2000 | WO2000021987A9 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |